This protocol is judged by an institutional evaluation board, an unbiased group that testimonials any clinical trials involving people. If a research involves a Routine I drug, once the board approves the protocol as moral, the researchers must apply for an investigational new drug (IND) range through the FDA.When under the affect of the drug, the